PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,355,296 | -46.2% | 131,200 | -31.7% | 0.02% | -46.7% |
| Q2 2023 | $2,519,388 | -70.7% | 192,173 | -75.0% | 0.03% | -74.4% |
| Q1 2023 | $8,609,561 | +33.4% | 770,086 | +0.6% | 0.12% | +36.0% |
| Q4 2022 | $6,455,677 | -29.4% | 765,798 | +39.6% | 0.09% | -32.8% |
| Q3 2022 | $9,138,000 | +43.8% | 548,512 | +27.1% | 0.13% | +30.6% |
| Q2 2022 | $6,354,000 | -43.9% | 431,632 | -5.5% | 0.10% | -46.7% |
| Q1 2022 | $11,330,000 | -2.3% | 456,655 | +26.3% | 0.18% | +10.8% |
| Q4 2021 | $11,597,000 | -4.2% | 361,607 | +7.5% | 0.17% | -16.2% |
| Q3 2021 | $12,101,000 | -18.4% | 336,313 | +0.0% | 0.20% | -28.5% |
| Q2 2021 | $14,836,000 | +153.2% | 336,273 | +162.5% | 0.28% | +113.1% |
| Q1 2021 | $5,859,000 | -33.7% | 128,092 | +0.1% | 0.13% | -44.4% |
| Q4 2020 | $8,833,000 | – | 127,976 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |